A phase III trial of safflor yellow injection for the treatment of angina pectoris with heart-blood stagnation syndrome in patients with coronary heart disease

Chinese Journal of New Drugs

Volumn 19, Issue 7, 2010, Pages 584-589

  Miao, Yang ^a   Li, Li Zhi ^a   Xu, Feng Qin ^a   Chen, Ke Yuan ^a   Wang, Xiao Fang ^a   Zhang, Dong ^a   Gao, Zhu Ye ^a   Zhao, Fu Hai ^a   Luo, Liang Tao ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Angina pectoris; Coronary heart disease; Heart blood stagnation syndrome; Phase III clinical trial; Safflor yellow injection

Indexed keywords

CHINESE DRUG; SAFFLOWER YELLOW; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

EID: 79953055288     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)